Azitromax 500 mg Norwegen - Norwegisch - Statens legemiddelverk

azitromax 500 mg

pfizer as - azitromycindihydrat - tablett, filmdrasjert - 500 mg

Azitromax 40 mg/ ml Norwegen - Norwegisch - Statens legemiddelverk

azitromax 40 mg/ ml

pfizer as - azitromycindihydrat - pulver til mikstur, suspensjon - 40 mg/ ml

Fenantoin RPH Pharmaceuticals 100 mg Norwegen - Norwegisch - Statens legemiddelverk

fenantoin rph pharmaceuticals 100 mg

rph pharmaceuticals ab - fenytoin - tablett - 100 mg

Imatinib Mylan 400 mg Norwegen - Norwegisch - Statens legemiddelverk

imatinib mylan 400 mg

mylan ab - imatinib - tablett, filmdrasjert - 400 mg

Imatinib Mylan 100 mg Norwegen - Norwegisch - Statens legemiddelverk

imatinib mylan 100 mg

mylan ab - imatinib - tablett, filmdrasjert - 100 mg

Modigraf 1 mg Norwegen - Norwegisch - Statens legemiddelverk

modigraf 1 mg

orifarm as - takrolimusmonohydrat - granulat til mikstur, suspensjon - 1 mg

Advagraf 3 mg Norwegen - Norwegisch - Statens legemiddelverk

advagraf 3 mg

orifarm as - takrolimusmonohydrat - depotkapsel, hard - 3 mg

Envarsus 4 mg Norwegen - Norwegisch - Statens legemiddelverk

envarsus 4 mg

paranova as - takrolimusmonohydrat - depottablett - 4 mg

Zitromax 500 mg Norwegen - Norwegisch - Statens legemiddelverk

zitromax 500 mg

orifarm as - azitromycindihydrat - tablett, filmdrasjert - 500 mg

Elzonris Europäische Union - Norwegisch - EMA (European Medicines Agency)

elzonris

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastiske midler - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).